Adverse Drug Reaction (ADR) reporting is a critical component of pharmacovigilance, ensuring patient safety and regulatory compliance. By accurately and timely reporting ADRs, healthcare professionals and pharmaceutical companies can identify potential safety risks and take appropriate actions.